SUGAMMADEX Mepha sol inj 500 mg/5ml 10 pce
7680690000028
CH-69000
V03AB35
15.01.0.
1 / 3
google
Details
- Product number
- 6900002
- CPT
- -
- Packaging group
- 10
- Unit
- Durchstechflasche(n)
- Composition
- sugammadexum 500 mg ut sugammadexum natricum 544 mg, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile ad solutionem pro 5 ml corresp. natrium 48.5 mg.
Articles (1)
Sugammadex-Mepha 500 mg/5 ml, Injektionslösung
Injektionslösung
10
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
544.0 MG | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
48.5 MG | Substance | HBESI |
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 69000
- Drug name
- Sugammadex-Mepha, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- V03AB35
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 21/07/2023
- Authorization expiration date
- 20/07/2028
- IT number
- 15.01.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SUGAMMADEX Mepha sol inj 500 mg/5ml 10 pce
- Description (DE)
- SUGAMMADEX Mepha Inj Lös 500 mg/5ml 10 Stk
- Market launch
- 21/07/2023
- Narcotic (BTM)
- No